Ealixir Statistics
Total Valuation
Ealixir has a market cap or net worth of 24.17 million. The enterprise value is 24.98 million.
| Market Cap | 24.17M |
| Enterprise Value | 24.98M |
Important Dates
The next estimated earnings date is Wednesday, November 11, 2026.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Ealixir has 60.12 million shares outstanding. The number of shares has increased by 2.68% in one year.
| Current Share Class | 60.12M |
| Shares Outstanding | 60.12M |
| Shares Change (YoY) | +2.68% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 63.14% |
| Owned by Institutions (%) | n/a |
| Float | 18.68M |
Valuation Ratios
The trailing PE ratio is 131.80.
| PE Ratio | 131.80 |
| Forward PE | n/a |
| PS Ratio | 6.12 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 136.25 |
| EV / Sales | 6.33 |
| EV / EBITDA | 81.09 |
| EV / EBIT | 82.45 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.88
| Current Ratio | 0.88 |
| Quick Ratio | 0.72 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.94 |
| Debt / FCF | n/a |
| Interest Coverage | 8.43 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -74.67% |
| Weighted Average Cost of Capital (WACC) | 5.73% |
| Revenue Per Employee | 197,417 |
| Profits Per Employee | 9,169 |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Ealixir has paid 47,146 in taxes.
| Income Tax | 47,146 |
| Effective Tax Rate | 20.45% |
Stock Price Statistics
The stock price has decreased by -57.23% in the last 52 weeks. The beta is 0.29, so Ealixir's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | -57.23% |
| 50-Day Moving Average | 1.31 |
| 200-Day Moving Average | 1.20 |
| Relative Strength Index (RSI) | 38.81 |
| Average Volume (20 Days) | 1,776 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.14 |
Income Statement
In the last 12 months, Ealixir had revenue of 3.95 million and earned 183,379 in profits. Earnings per share was 0.00.
| Revenue | 3.95M |
| Gross Profit | 3.08M |
| Operating Income | 303,014 |
| Pretax Income | 230,525 |
| Net Income | 183,379 |
| EBITDA | 308,122 |
| EBIT | 303,014 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 89,868 in cash and 904,776 in debt, with a net cash position of -814,908 or -0.01 per share.
| Cash & Cash Equivalents | 89,868 |
| Total Debt | 904,776 |
| Net Cash | -814,908 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -605,826 |
| Book Value Per Share | -0.01 |
| Working Capital | -417,299 |
Cash Flow
In the last 12 months, operating cash flow was -633,073 and capital expenditures -5,787, giving a free cash flow of -638,860.
| Operating Cash Flow | -633,073 |
| Capital Expenditures | -5,787 |
| Depreciation & Amortization | 5,108 |
| Net Borrowing | 781,010 |
| Free Cash Flow | -638,860 |
| FCF Per Share | -0.01 |
Margins
Gross margin is 77.96%, with operating and profit margins of 7.67% and 4.64%.
| Gross Margin | 77.96% |
| Operating Margin | 7.67% |
| Pretax Margin | 5.84% |
| Profit Margin | 4.64% |
| EBITDA Margin | 7.80% |
| EBIT Margin | 7.67% |
| FCF Margin | n/a |
Dividends & Yields
Ealixir does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.68% |
| Shareholder Yield | -2.68% |
| Earnings Yield | 0.76% |
| FCF Yield | -2.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on July 8, 2020. It was a reverse split with a ratio of 0.04.
| Last Split Date | Jul 8, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.04 |
Scores
Ealixir has an Altman Z-Score of -14.38 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.38 |
| Piotroski F-Score | 3 |